close

Enter

Log in using OpenID

Glucose Biosensors Market Trends, 2024

embed
Glucose biosensors industry is expected to observe soaring growth owing to escalating diabetic patient population worldwide.Rising occurrence of diabetes worldwide is the main factor contributing towards the expansion of this industry.
Your Catalyst To a Lucrative Business
Glucose Biosensors Market Analysis, Size, Share, Growth, Industry
Trends and Forecast to 2024 | Hexa Research
" Glucose biosensors industry is expected to observe
soaring growth owing to escalating diabetic patient
population worldwide.Rising occurrence of diabetes
worldwide is the main factor contributing towards the
expansion of this industry."
The worldwide glucose biosensors market size is expected to surpass USD 31 billion by 2024. It was valued
about USD 15.3 billion in 2015. The high incidence of diabetes is a key factor that drives this market.
Technological breakthroughs in monitoring glucose levels can spur market demand. Biosensors are devices that
detect biological changes in the body and display those via electronic indicators. These changes (commonly
known as analytes) could be gases, organic compounds, bacteria, and others.
Glucose biosensors can sense glucose levels within the body. They are small & minimally invasive devices that
assess glucose levels in outpatient settings. Need for reliable biosensors still pose a market challenge.
Alternative methods, like laboratory tests can restrict market growth. But several companies are investing in
R&D (research and development) to improve the current technology.
The global Glucose Biosensors Market is segmented on the basis of types, end-users, and regions. The two
types are amprometric and fluorescent. Amperometric biosensors are extensively available. They function by
way of glucose oxidase. These devices combine glucose with oxygen to produce hydrogen peroxide. The
electrode identifies hydrogen peroxide and accurately measures glucose levels from it.
Fluorescent biosensors are estimated to capture major market shares over the forecast period (2016-2024).
These biosensors measure glucose levels by detecting sensitive proteins via the fluorescence process. Better
operational life of these devices may benefit the market in the years ahead.
Browse Details of [email protected] https://www.hexaresearch.com/research-report/glucose-biosensors-market
Follow Us:
Your Catalyst To a Lucrative Business
End-users are home care diagnostics, hospitals, and others. Others include diagnostic laboratories, res earch
institutes, and clinical. Home care diagnostics held over 46% market shares in 2015. This segment comprises the
adoption hand-held glucose meters. These devices deliver quick & efficient results and reduce the need for
frequent hospital visits. ‘Hospitals’ may expand significantly over the next eight years. It could grow a 10.3%
CAGR from 2015 to 2022.
Regions in the global Glucose Biosensors Market are North America, Latin America, Middle East & Africa (MEA),
Asia Pacific, and Europe. North America dominated the worldwide market with nearly 37% shares in 2015.
Growing cases of diabetes coupled with technological advancements in the region can boost revenues during
the forecast period. Europe may be the second largest market in terms of revenue after North America.
Asia Pacific is expected to grow at a CAGR of 13% from 2015 to 2022. India & China jointly accounted for over
65% of the global diabetic base in 2013. This could benefit the worldwide market in the years ahead.
Major players in the glucose biosensor industry are LifeScan Inc., Abbott Laboratories, F. Hoffmann-La Roche
AG, and Bayer AG. These companies held over 70% of the total market shares in 2014. They focus on product
development, partnerships, and collaborations for long term growth and market sustenance. For instance,
LifeScan introduced a new glucose monitoring system, OneTouch Verio in 2015. It measures glucose levels via a
color-coded indicator.
Mayo Clinic, Gentag, NovioSense, and Fraunhofer Institute for Microelectronic Circuits & Systems entered a
collaboration to fight against type 2 diabetes, in 2015. They aim at equipping smartphones with low-cost
diabetes monitoring systems. The technology thus developed may be employed in a number of diabetes
applications, such as eye sensors, skin patches, long-terms implantable sensors and so on. All of these devices
can be controlled via smartphones. Currently, carbon nanotubes are gaining popularity due to their exceptional
physical and electrical properties. These nanotubes work well with glucose biosensors by providing support for
enzyme control.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinicaldiagnostics-industry
Follow Us:
Your Catalyst To a Lucrative Business
Table of Content of Glucose Biosensors Market
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Glucose biosensors Market - Industry Summary and Key Buying Criteria, 2016 - 2024
Chapter 3. Glucose biosensors Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2016 - 2024
3.3. Glucose biosensors: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Rising prevalence of diabetes
3.3.1.2. Presence of a strong range of products in pipeline
3.3.1.3. Growing prevalence of lifestyle induced disorders such as obesity
3.3.2. Market restraint analysis
3.3.2.1. Presence of alternative methods
3.4. Glucose biosensors market: Industry trend analysis
3.5. Glucose biosensors Market - PESTEL Analysis
3.6. Glucose biosensors Industry analysis - Porter's Five Forces Model
3.7. Glucose biosensors: Company Market Share Analysis (%), 2016
3.8. Key opportunities prioritized
Chapter 4. Glucose Biosensors End-User Application Outlook
4.1. Glucose Biosensors Revenue Share (%) Analysis, by End-User Application, 2016 & 2024
4.2. Hospital
4.2.1. Hospital market revenue, by region, 2016 to 2024 (USD Million)
4.3. Homecare Diagnostics
4.3.1. Homecare diagnostics market revenue, by region, 2016 to 2024 (USD Million)
4.4. Others
4.4.1. Others market revenue, by region, 2016 to 2024 (USD Million)
Chapter 5. Glucose Biosensors Regional Outlook
5.1. Glucose Biosensors Market Share (%) Analysis, by Region, 2016 & 2024
5.2. North America
5.2.1. U.S.
5.2.1.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.2.2. Canada
5.2.2.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.3. Europe
Follow Us:
Your Catalyst To a Lucrative Business
5.3.1. Germany
5.3.1.1. glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.3.2. U.K.
5.3.2.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.3.3. Rest of Europe
5.3.3.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.4. Asia Pacific
5.4.1. China
5.4.1.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.4.2. India
5.4.2.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.4.3. Rest of Asia Pacific
5.4.3.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.5. MEA
5.5.1. South Africa
5.5.1.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.5.2. Saudi Arabia
5.5.2.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.5.3. Rest of MEA
5.5.3.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.6.2. Mexico
5.6.2.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
5.6.3. Rest of Latin America
5.6.3.1. Glucose biosensors market, by end-user application, 2016 - 2024 (USD Million)
Chapter 6. Competitive Landscape
6.1. Roche Diagnostics
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. LifeScan Inc.
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Abbott Laboratories
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Bayer
6.4.1. Company Overview
Follow Us:
Your Catalyst To a Lucrative Business
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. Medtronic Inc.
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Pinnacle Medical Solutions Inc.
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. AgaMatrix Inc.
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Sanofi S.A.
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. BioSense Medical Devices, LLC
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. Nova Biomedical
6.10.1. Company Overview
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives
Follow Us:
Your Catalyst To a Lucrative Business
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: [email protected]
Website - http://www.hexaresearch.com/
Visit our Blog: hexaresearch1.blogspot.com
Follow Us:
1/--pages
Report inappropriate content